News Focus
News Focus
icon url

Biowatch

01/23/12 12:47 AM

#135480 RE: Superfly15 #135475

How many decades has CVM touted Multikine, which has no patent protection?

I realize the CEO pulls down a huge salary, but when do you decide to call it quits and retire?

How many clinical trials can you run without making it to market?
icon url

DewDiligence

01/26/12 9:24 AM

#135755 RE: Superfly15 #135475

One investing rule that never changes—a folksy shareholder letter from the CEO is soon followed by a financing transaction:

http://finance.yahoo.com/news/CEL-SCI-Corporation-Raise-5-bw-3667798450.html?x=0